Willow Biosciences Inc

Company Profile

Willow Biosciences Inc had its IPO on under the ticker symbol CANSF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Willow Biosciences Inc has a staff strength of 32 employees.

Stock update

Shares of Willow Biosciences Inc opened at $0.06 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.06 - $0.06, and closed at $0.06.

This is a +10.73% increase from the previous day's closing price.

A total volume of 2,000 shares were traded at the close of the day’s session.

In the last one week, shares of Willow Biosciences Inc have increased by +10.73%.

Willow Biosciences Inc's Key Ratios

Willow Biosciences Inc has a market cap of $12.42 million, indicating a price to book ratio of 0.6411 and a price to sales ratio of 31.6717.

In the last 12-months Willow Biosciences Inc’s revenue was $1.10 million with a gross profit of $821000 and an EBITDA of $-16968000. The EBITDA ratio measures Willow Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Willow Biosciences Inc’s operating margin was -1680.37% while its return on assets stood at -52.47% with a return of equity of -85.27%.

In Q1, Willow Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 5566.7%.

Willow Biosciences Inc’s PE and PEG Ratio

Forward PE

67.1141

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 67.1141 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Willow Biosciences Inc’s profitability.

Willow Biosciences Inc stock is trading at a EV to sales ratio of 5.6168 and a EV to EBITDA ratio of -214.1721. Its price to sales ratio in the trailing 12-months stood at 31.6717.

Willow Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$13.50 million

Total Liabilities

$1.72 million

Operating Cash Flow

$0

Capital Expenditure

$524000

Dividend Payout Ratio

0%

Willow Biosciences Inc ended 2024 with $13.50 million in total assets and $0 in total liabilities. Its intangible assets were valued at $13.50 million while shareholder equity stood at $11.77 million.

Willow Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $1.72 million in other current liabilities, in common stock, $-113426000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.47 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Willow Biosciences Inc’s total current assets stands at $11.51 million while long-term investments were $0 and short-term investments were $20000.00. Its net receivables were $452000.00 compared to accounts payable of $0 and inventory worth $243000.00.

In 2024, Willow Biosciences Inc's operating cash flow was $0 while its capital expenditure stood at $524000.

Comparatively, Willow Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.06

52-Week High

$0.152

52-Week Low

$0.058

Analyst Target Price

$

Willow Biosciences Inc stock is currently trading at $0.06 per share. It touched a 52-week high of $0.152 and a 52-week low of $0.152. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.07 and 200-day moving average was $0.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2789.9% of the company’s stock are held by insiders while 12.1% are held by institutions.